RxCompounded — Not FDA-Approved
Compounded Tirzepatide Injectable
$349/monthor $849 for 3 months · $1,589 for 6 months · $2,988 for 12 months
Tirzepatide is a dual GIP/GLP-1 receptor agonist prescribed for weight management
Physician-supervised care with dose adjustments included and no membership fee
A once-weekly injectable prescribed for weight management
Helps regulate appetite and slows how quickly food moves through the stomach
Used alongside lifestyle changes and continued provider care
Tirzepatide is a dual GIP/GLP-1 receptor agonist
Mimics naturally-occurring hormones released after eating to signal fullness
Helps regulate appetite and blood sugar
Slows digestion to keep you feeling full longer
Compounded to order at a licensed U.S. pharmacy
Compounded tirzepatide is not FDA-approved and is prepared by a licensed compounding pharmacy.
Administered as a once-weekly subcutaneous injection
Your provider sets your starting dose and titration schedule
Rotate injection sites with each dose
Store as directed by your pharmacy
Requires a prescription from a licensed provider after an online consultation. Not everyone qualifies. A provider decides if treatment is right for you. This is a compounded medication. Compounded drugs are not FDA approved. Subscriptions renew automatically and are charged at the interval shown at checkout until you cancel. To cancel, contact your care team through your Remo portal. Individual results vary.
